Thiophen-3-amine hydrochloride → 2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]-N-(thiophen-3-yl)acetamide

HRID 1631555Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1631555
[N:1]1([C:7]2[N:8]=[C:9]([CH2:14][C:15]([O-:17])=O)[NH:10][C:11](=[O:13])[CH:12]=2)[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[Na+].Cl.[NH2:20][C:21]1[CH:25]=[CH:24][S:23][CH:22]=1>>[N:1]1([C:7]2[N:8]=[C:9]([CH2:14][C:15]([NH:20][C:21]3[CH:25]=[CH:24][S:23][CH:22]=3)=[O:17])[NH:10][C:11](=[O:13])[CH:12]=2)[CH2:2][CH2:3][O:4][CH2:5][CH2:6]1

Komponenten

3

Edukt 2

HCID 12413181Thiophen-3-amine hydrochlorideHCID 136041844Sodium (4-morpholin-4-yl-6-oxo-1,6-dihydropyrimidin-2-yl)acetate

Produkt 1

HCID 1363521782-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]-N-(thiophen-3-yl)acetamideAusbeute 82,2 %

Versuchsvorschrift

The product is prepared according to the procedure described in Example 5, using 250 mg of sodium [4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate and 400 mg of 3-aminothiophene hydrochloride in place of the 2,4-difluoroaniline. 252 mg of 2-[4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]-N-(thiophen-3-yl)acetamide are obtained in the form of a beige solid, the characteristics of which are the following:

Aufarbeitung

  1. customThe product is prepared

Quellen und Nachweise

ORD-Eintrag
ord-49ad1cd375ac43e0a3da6d62f75b4dcb
Quelldatensatz
uspto-grants-2014_07
Patentnummer
US08791255B2

Notizen zur Reaktion

Wird geladen…